1-3 of 3
Stefan Barth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BARs ( B -cell receptor a ntigens for r everse targeting): A Novel and Ultimately Specific Treatment Concept for B-Cell Neoplasms

Michael Pfreundschuh, MD, Lorenz Thurner, MD, Stefan Barth, Prof.Dr., Diana Pickert, Natalie Fadle, Maria Kemele, Evi Regitz, Frank Neumann, PhD, Thomas Nachreiner, Dr., Klaus-Dieter Preuss, PhD
Journal: Blood
Blood (2015) 126 (23): 3995.
https://doi.org/10.1182/blood.V126.23.3995.3995
Published: 2015
Journal Articles

Ki-4(scFv)–ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice

Stefan Barth, Michael Huhn, Bärbel Matthey, Samir Tawadros, Roland Schnell, Timo Schinköthe, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2000) 95 (12): 3909–3914.
https://doi.org/10.1182/blood.V95.12.3909
Published: 2000
Journal Articles

A Phase-I Study of an Anti-CD25 Ricin A-Chain Immunotoxin (RFT5-SMPT-dgA) in Patients With Refractory Hodgkin's Lymphoma

Andreas Engert, Volker Diehl, Roland Schnell, Andrea Radszuhn, Maria-Theresia Hatwig, Silke Drillich, Gisela Schön, Heribert Bohlen, Hans Tesch, Martin-Leo Hansmann, Stefan Barth, John Schindler, Victor Ghetie, Jonathan Uhr, Ellen Vitetta
Journal: Blood
Blood (1997) 89 (2): 403–410.
https://doi.org/10.1182/blood.V89.2.403
Published: 1997